Want to join the conversation?
FDA accepts filing of $AGN's supplemental New Drug Application for single-dose administration of DALVANCE (dalbavancin) for treatment of adults with acute bacterial skin & skin structure infections caused by Gram-positive bacteria, including MRSA. DALVANCE is currently administered in a two-dose regimen of 1000 mg followed by 500 mg one week later.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!